TG Therapeutics (TGTX) Margins & Profitability 2020-2026

Gross, EBITDA, operating, and net margin trends

Margins

Profit margins across the income statement

Gross Margin: 83.6%
EBITDA Margin: 17.0%
Op. Margin: 17.0%
Net Margin: 9.7%

Op. margin of 17.0% is up 9.8% YoY — cost efficiency is improving. Net margin at 9.7% and gross margin of 83.6% — earnings take a bigger bite when COGS stays lean..

Gross Margin (%)

Revenue left after direct cost of goods sold

EBITDA Margin (%)

Operating profitability independent of capital structure

Operating & Net Margins (%)

How much of each dollar becomes profit